Publisher
Springer Nature Singapore
Reference106 articles.
1. Anampa J, Makower D, Sparano JA (2015) Progress in adjuvant chemotherapy for breast cancer: an overview. Br J Cancer 13:195
2. Bamett G, Wilkinson J, Moody AM et al (2009) A randomized controlled trial of forward-planned radiotherapy (IMRT) for early breast cancer: baseline characteristics and dosimetry results. Radiother Oncol 92:34
3. Begg AC, Stewart F, Vens C (2011) Strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer 11:239–253
4. Blok EJ, Kroep JR, Meershoek-Klein Kranenbarg E et al (2016) Optimal duration of extended letrozole treatment after 5 years of adjuvant endocrine therapy; results of the randomized phase III ideal trial breast cancer symposium. San Antonio, TX, S-04: p2-09-01
5. Baselga J, Cortés J, Kim SB, Im SA, Hegg R, Im YH, Roman L, Pedrini JL, Pienkowski T, Knott A et al (2012) Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer. N Engl J Med 366:109–119